|
1
|
DR BaldwinLung cancer: investigation and
stagingMedicine36155161200810.1016/j.mpmed.2007.12.004
|
|
2
|
A JemalR SiegelE WardCancer statistics,
2008CA Cancer J Clin587196200810.3322/CA.2007.0010
|
|
3
|
MF LeberT EfferthMolecular principles of
cancer invasion and metastasis (Review)Int J
Oncol34881895200919287945
|
|
4
|
L BorsigThe role of platelet activation in
tumor metastasisExpert Rev Anticancer
Ther812471255200810.1586/14737140.8.8.124718699763
|
|
5
|
T TsuruoN FujitaPlatelet aggregation in
the formation of tumor metastasisProc Jpn Acad Ser B Phys Biol
Sci84189198200810.2183/pjab.84.18918941298
|
|
6
|
AF ChambersGN NaumovHJ VargheseCritical
steps in hematogenous metastasis: an overviewSurg Oncol Clin N
Am10243255200111382585
|
|
7
|
TR GeigerDS PeeperMetastasis
mechanismsBiochim Biophys Acta1796293308200919683560
|
|
8
|
JA JoyceJW PollardMicroenvironmental
regulation of metastasisNat Rev
Cancer9239252200810.1038/nrc2618
|
|
9
|
S NobleJ PasiEpidemiology and
pathophysiology of cancer-associated thrombosisBr J
Cancer13S2S92008
|
|
10
|
A AmirkhosraviSA MousaM AmayaInhibition of
tumor cell-induced platelet aggregation and lung metastasis by the
oral GPIIb/IIIa antagonist XV454Thromb
Haemost90549554200312958625
|
|
11
|
E SierkoMZ WojtukiewiczInhibition of
platelet function: does it offer a chance of better cancer
progression control?Semin Thromb
Hemost33712721200710.1055/s-2007-99154018000800
|
|
12
|
RJ LudwigMP SchönWH BoehnckeP-selectin: a
common therapeutic target for cardiovascular disorders,
inflammation and tumour metastasisExpert Opin Ther
Targets1111031117200710.1517/14728222.11.8.110317665981
|
|
13
|
A MassaguerP EngelV TovarCharacterization
of platelet and soluble-porcine P-selectin (CD62P)Vet Immunol
Immunopathol96169181200310.1016/S0165-2427(03)00163-614592730
|
|
14
|
R SimanekR VormittagC AyHigh platelet
count associated with venous thromboembolism in cancer patients:
results from the Vienna Cancer and Thrombosis Study (CATS)J Thromb
Haemost8114120201010.1111/j.1538-7836.2009.03680.x19889150
|
|
15
|
HM VerheulHM PinedoThe importance of
platelet counts and their contents in cancerClin Cancer
Res932193221200312960106
|
|
16
|
M IkedaH FurukawaH ImamuraPoor prognosis
associated with thrombocytosis in patients with gastric cancerAnn
Surg Oncol9287291200210.1007/BF0257306711923136
|
|
17
|
A IwasakiW HamanakaT HarnadaSignificance
of platelet counts in patients who underwent surgical treatment for
lung metastasisInt Surg92103109200717518253
|
|
18
|
V Dymicka-PiekarskaJ Matowicka-KarnaM
GrykoRelationship between soluble P-selectin and inflammatory
factors (interleukin-6 and C-reactive protein) in colorectal
cancerThromb
Res120585590200710.1016/j.thromres.2006.11.00217169411
|
|
19
|
L ErpenbeckMP SchönDeadly allies: the
fatal interplay between platelets and metastasizing cancer
cellsBlood11534273436201010.1182/blood-2009-10-24729620194899
|
|
20
|
P JuraszD Alonso-EscolanoMW
RadomskiPlatelet-cancer interactions: mechanisms and pharmacology
of tumour cell-induced platelet aggregationBr J
Pharmacol143819826200410.1038/sj.bjp.070601315492016
|
|
21
|
M TrikhaZ ZhouJ TimarMultiple roles for
platelet GPIIb/IIIa and αvβ3 integrins in tumor growth,
angiogenesis, and metastasisCancer Res62282428332002
|
|
22
|
B FuchsU BuddeA SchulzFlow-based
measurements of von Willebrand factor (VWF) function: binding to
collagen and platelet adhesion under physiological shear rateThromb
Res125239245201010.1016/j.thromres.2009.08.02019853893
|
|
23
|
MR CominettiAC MartinJU RibeiroInhibition
of platelets and tumor cell adhesion by the disintegrin domain of
human ADAM9 to collagen I under dynamic flow
conditionsBiochimie9110451052200910.1016/j.biochi.2009.05.01219505527
|
|
24
|
L BorsigR WongRO HynesSynergistic effects
of L- and P-selectin in facilitating tumor metastasis can involve
non-mucin ligands and implicate leukocytes as enhancers of
metastasisProc Natl Acad Sci
USA9921932198200210.1073/pnas.26170409811854515
|
|
25
|
K BaumannD KowalczykT GutjahrSulfated and
non-sulfated glycopeptide recognition domains of P-selectin
glycoprotein ligand 1 and their binding to P- and E-selectinAngew
Chem Int Ed Engl4831743178200910.1002/anie.20080599919322854
|
|
26
|
M IiizumiS MohintaS BandyopadhyayK
WatabeTumor-endothelial cell interactions: therapeutic
potentialMicrovasc
Res74114120200710.1016/j.mvr.2007.04.00217498748
|
|
27
|
AP SkubitzAdhesion moleculesCancer Treat
Res1073053292002
|
|
28
|
OJ McCartySA MousaPF BrayK
KonstantopoulosImmobilized platelets support human colon carcinoma
cell tethering, rolling, and firm adhesion under dynamic flow
conditionsBlood9617891797200010961878
|
|
29
|
K Leycell adhesion under
flowMicrocirculation1612200910.1080/10739680802644415
|
|
30
|
MA ArnaoutSL GoodmanJP XiongStructure and
mechanics of integrin-based cell adhesionCell
Biology19495507200717928215
|
|
31
|
HB WangJT WangL ZhangP-selectin primes
leukocyte integrin activation during inflammationNat
Immunol8882892200710.1038/ni149117632516
|
|
32
|
A GogaliK CharalabopoulosS
ConstantopoulosIntegrin receptors in primary lung cancerExp
Oncol261061102004
|
|
33
|
KN SyrigosN KatirtzoglouE KotteasK
HarringtonAdhesion molecules in lung cancer: implications in the
pathogenesis and managementCurr Pharm
Des1421732183200810.2174/13816120878574016218781970
|
|
34
|
SR BarthelJD GavinoL DeschenyCJ
DimitroffTargeting selectins and selectin ligands in inflammation
and cancerExpert Opin Ther
Targets1114731491200710.1517/14728222.11.11.147318028011
|
|
35
|
L BorsigAntimetastatic activities of
modified heparins: selectin inhibition by heparin attenuates
metastasisSemin Thromb
Hemost33540546200710.1055/s-2007-98208617629852
|
|
36
|
DD MaratheA Buffone JrEV
ChandrasekaranFluorinated per-acetylated GalNAc metabolically
alters glycan structures on leukocyte PSGL-1 and reduces cell
binding to
selectinsBlood11513031312201010.1182/blood-2009-07-23148019996411
|
